logo
A manager's guide to helping grieving employees

A manager's guide to helping grieving employees

Fast Company11-05-2025

In the UK, it is currently Dying Matters Awareness Week. Grief—and the impact of death and loss—is something that nearly all of us will experience at some point in our working lives. Despite this, many workplaces are not equipped to have these tricky conversations and are unsure how to best support their staff with their mental well-being while grieving. At This Can Happen, we conducted an in-depth, two-stage research project into how workplaces are supporting employees with grief— the Grief In The Workplace Report —and the findings are eye-opening.
We found that 87% of respondents with lived experience felt grief had impacted their mental well-being, yet 46% felt that they did not have enough time to grieve and 51% did not feel supported by their organization. This is a critical issue for managers and leaders in the workplace that is impacting not only employee mental well-being, but also the ability for staff to perform at work. In fact, 76% said since returning to work they had not received any communications from managers or leadership in relation to their grief, and 76% also said they felt their loss had affected their performance in their immediate return to work.
So, how can employers help? Here are five ways.
1. Break the taboo in speaking about grief and bereavement
These conversations should be led from the top-down to tackle stigma and build psychological safety in the workplace. This is the responsibility of both leadership and line managers. For example, if members of leadership have lived experience of grief and loss, consider how personal storytelling from these individuals could have a transformative impact on staff likelihood to share their own challenges. This could take the form of an internal blog, a panel discussion, or even an update in a company meeting. Line managers can then pick up on this note and continue these conversations in catch-ups with line reports, encouraging open and honest conversation about mental well-being to build trust, so that employees know that they can immediately go to their manager when they need support.
2. Put the right support in place
Providing the right resources—and ensuring that staff know where to find them—is crucial. Our research shows that this is currently an area in which businesses are struggling, with 37% of respondents unsure about what resources were currently available to support them with grief. Make sure that you have a comprehensive Employee Assistance Programme (EAP) in place, which is a confidential service that supports staff—and sometimes their family members—with their health, including counseling, referrals, and expert advice. Consider creating worksheets with tips and advice about living through bereavement, along with helpful links that employees might want to explore for further reading or conversations. Finally, ensure that line managers are fully trained in having these conversations in the workplace, and understanding what resources your organization has in place, so that they can signpost staff correctly and efficiently.
3. Be open, empathetic, and human in your approach
This might sound like an obvious one, but it's not; so many leaders and managers approach grief and bereavement from a policy-led perspective, or avoid the conversation altogether because they are afraid of saying what could be perceived as the 'wrong thing.' Some 64% of respondents in our research had not heard their managers talking openly about bereavement. Take the time to understand what employees are thinking and feeling in terms of their grief, and what they need right now—keeping in mind that grief is not one linear path forward, but rather a journey that's filled with peaks and troughs over time. This can be heightened around key moments such as anniversaries and birthdays. Keep the lines of communication open to understand what employees need at any given moment, and how you as an employer can really make a tangible impact in the support you offer.
4. Give employees experiencing grief both space and flexibility at work
Make sure employees who have uttered a loss know that you as an employer or line manager are there for them to speak to if they need it, but also give them the time and space to process their grief as needed. As much as you can within your workplace and industry, offer flexible working arrangements to bereaved staff. The thought of going into the office following a bereavement can sometimes be an overwhelming prospect; try to understand the impacts of grief in the short-, medium- and long-term, and understand where staff might benefit from flexible working arrangements.
5. Consider how you can provide ongoing support
For example, if resources allow, consider meeting with a psychologist to explain how to set up bereavement support, and ensure that this is baked into the heart of an organization, rather than sitting solely in a policy. From here, speak to staff and understand if there's anything further that they would like to set up from a grassroots perspective. A lot of powerful work that we have seen in this space has been created and run organically by employees—lunch-and-learn sessions on lived experience with grief or quarterly drop-in 'grief cafés,' for instance.
These are all thought-starters on how best to support employees experiencing grief. The most important thing that you can do as a leader or manager is to be kind, empathetic and understanding to the challenges that these team members are facing, and listen with an open ear around how best to support them. You'll soon see the benefits of this, not just on employee mental well-being, but in terms of presenteeism and productivity as well.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hair Cortisone Predicts Metabolic Syndrome in Young Adults
Hair Cortisone Predicts Metabolic Syndrome in Young Adults

Medscape

time3 hours ago

  • Medscape

Hair Cortisone Predicts Metabolic Syndrome in Young Adults

Long-term biological stress, measured using hair glucocorticoid levels, was strongly associated with the presence of metabolic syndrome (MetS) and its components such as waist circumference and triglycerides, with the association being particularly pronounced in younger adults for hair cortisone levels. METHODOLOGY: Researchers in the Netherlands conducted a cross-sectional study to investigate the relationship between hair glucocorticoid levels and the presence of MetS and its components in 1405 adult participants (median age, 49 years; 73.6% women) from the Netherlands Study of Depression and Anxiety cohort. Levels of hair glucocorticoids (cortisol and cortisone) were measured using liquid chromatography-tandem mass spectrometry. Outcomes were the presence of MetS and its individual components that included high-density lipoprotein cholesterol, fasting glucose, and triglyceride levels; diastolic blood pressure; and waist circumference. This study also assessed whether age (≤ 49 vs ≥ 50 years) modified the relationship between hair glucocorticoids and MetS. TAKEAWAY: Hair cortisol (odds ratio [OR], 1.27) and cortisone (OR, 1.32; P < .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; P = .003). < .001 for both) levels were strongly associated with MetS, with the association between hair cortisone and MetS being significantly modified by age (OR, 0.78; = .003). The link between hair glucocorticoids and MetS was stronger in younger participants than in older ones for both hair cortisol (OR, 1.52 vs 1.20) and hair cortisone (OR, 1.95 vs 1.14). Hair cortisol and cortisone levels were positively correlated with waist circumference ( P < .001 for both) and triglyceride levels ( P < .025 for both); hair cortisol, but not cortisone, levels were also positively associated with diastolic blood pressure ( P = .034) and negatively associated with high-density lipoprotein cholesterol levels ( P = .035). IN PRACTICE: "In the future, [the study] findings can be used to identify individuals with increased cardiovascular risk," the authors wrote. SOURCE: This study was led by Susanne Kuckuck, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. It was published online on June 03, 2025, in The Journal of Clinical Endocrinology & Metabolism . LIMITATIONS: The study population was predominantly Caucasian, which limited the generalisability of the findings to other populations and ethnic minorities. Information on diet was not collected; hence, the potential influence of nutritional factors on glucocorticoid metabolism could not be assessed. This study could not show whether elevated hair glucocorticoid levels caused MetS due to its cross-sectional design. DISCLOSURES: This study was supported by Stress in Action, a research project financially supported by the Dutch Research Council and the Dutch Ministry of Education, Culture and Science. The authors declared having no conflicts of interest.

Prevalence of Autoimmune Diseases Rose in UK Pregnancies
Prevalence of Autoimmune Diseases Rose in UK Pregnancies

Medscape

time3 hours ago

  • Medscape

Prevalence of Autoimmune Diseases Rose in UK Pregnancies

Over the past two decades, the prevalence of autoimmune diseases among pregnant women in the UK has significantly increased, with psoriasis being the most common condition. The likelihood of diagnosis varied across sociodemographic factors, including age, ethnicity, and socioeconomic status. METHODOLOGY: Researchers conducted a UK population-based retrospective cohort study using routinely collected primary care data from Clinical Practice Research Datalink Gold and Aurum pregnancy registers. This study included 5,165,960 pregnancies in 2,831,472 women aged 15-49 years from 2000 to 2021, including 185,208 pregnancies in 100,655 women with a coded diagnosis of autoimmune disease. Researchers evaluated the prevalence trend, calculated annually for both overall and each of 17 autoimmune diseases, during pregnancy via diagnostic codes and analysed their associations with sociodemographic factors. TAKEAWAY: The overall prevalence of autoimmune diseases during pregnancy increased from 3.5% in 2000 to 4.7% in 2021; psoriasis was the most prevalent condition, followed by inflammatory bowel disease and rheumatoid arthritis between 2000 and 2010 and type 1 diabetes and inflammatory bowel disease in 2010-2021. The prevalence of most of the autoimmune diseases significantly increased between 2000 and 2021, with the steepest rise observed in Hashimoto's thyroiditis (+6.22%), coeliac disease (+6.20%), and alopecia areata (+4.75%). Women living in less deprived areas had higher odds of autoimmune diseases during pregnancy than those living in more deprived areas (adjusted odds ratio [aOR], 1.10; 95% CI, 1.07-1.14), and Black women had significantly lower odds than White women (aOR, 0.48; 95% CI, 0.45-0.51). Compared with women aged 15-20 years, those aged 21-30 years (aOR, 1.17; 95% CI, 1.14-1.20), 31-40 years (aOR, 1.50; 95% CI, 1.45-1.55), and 41-50 years (aOR, 1.75; 95% CI, 1.68-1.82) had increased odds of being diagnosed with autoimmune disease before pregnancy. IN PRACTICE: "This study gives a clear estimate of the burden of autoimmune diseases in pregnancy in the UK and the possible association with various demographic factors, and will help the process of improving maternity care for women with these health conditions," the authors wrote. SOURCE: This study was led by Megha Singh, PhD, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, England. It was published online on June 02, 2025, in The Lancet Rheumatology . LIMITATIONS: This study did not include some rare autoimmune diseases like dermatomyositis. Although the use of primary care data reduced entry-level coding biases, improvements in recording practices over time might affect data quality and completeness, potentially affecting observed trends. Additionally, this study may have underestimated the prevalence of autoimmune diseases since most cases are diagnosed and managed in secondary care. DISCLOSURES: This study was supported by the Strategic Priority Fund "Tackling multimorbidity at scale" programme. One author initially worked at the University of Birmingham and later joined AstraZeneca and currently holds an honorary contract with the University of Birmingham.

Is Elon Musk's Ketamine Use Encouraging Dangerous Self-Medication?
Is Elon Musk's Ketamine Use Encouraging Dangerous Self-Medication?

Forbes

time3 hours ago

  • Forbes

Is Elon Musk's Ketamine Use Encouraging Dangerous Self-Medication?

Elon Musk's candid admission about using ketamine for depression made headlines. So did Naomi Campbell's extensive vitamin regimen and Gwyneth Paltrow's jade eggs. And these are just the careinfluencers you've heard of. In the age of social media, celebrities and patients alike aren't just endorsing products — they're dispensing medical advice, often with zero qualifications. Welcome to the era of 'carefluencers' — a growing class of influencers who peddle wellness tips, off-label drug use and even prescription workarounds to millions of followers. And this is not surprising:, a new Healthline/YouGov survey shows Americans of all ages are increasingly turning to social media for health information — and skipping preventive care. But behind the slick posts and quick fixes lies a dangerous truth: when trust in science erodes, real people pay the price—with misdiagnoses, harmful self-medication, and preventable suffering. Celebrities like Musk or longevity biohacker Bryan Johnson wield immense influence. A single tweet can send ketamine clinic inquiries soaring or spark a run on unproven biohacks. But there's a critical difference between medical treatment and recreational experimentation: Healthcare is increasingly consumer-driven — fueled by viral demand for everything from Ozempic to off-label ADHD meds — and physicians are feeling the pressure from the requests. Patients now rate physicians like Uber drivers, and nobody wants a bad review, especially from a VIP. It's not too difficult to imagine a celebrity demanding Adderall for focus or ketamine for mood boosts. If the doctor says no, they'll find someone who says yes. Money becomes power, and without clinical oversight, that power enables harmful behaviors. The result? A perfect storm where hyperagency — the celebrity belief that rules simply don't apply — collides with narcissistic influence and unchecked social capital. These forces distort reality: patient demands override medical judgment, while unvetted advice from carefluencers (who face zero accountability for their 'recommendations') fuels prescription abuse epidemics. It's a system where fame trumps science, and the casualties are evidence-based medicine itself. The dangers of carefluencers—from Musk's ketamine takes to viral 'biohacks'—reveal a hard truth: celebrity endorsements work for fashion trends, not healthcare. When lives are at stake, trust belongs to clinicians, not unqualified influencers. Unlike a bad outfit choice, the consequences of misguided medical advice can't be returned or refunded.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store